Bruno Revol, Théo Willeman, Marc Manceau, Véronique Dumestre-Toulet, Jean-Michel Gaulier, Alexandra Boucher, Célian Bertin, Hélène Eysseric-Guérin, Nathalie Fouilhé Sam-Laï
{"title":"DRAMES and DTA databases: Complementary tools to monitor drug-related deaths in France.","authors":"Bruno Revol, Théo Willeman, Marc Manceau, Véronique Dumestre-Toulet, Jean-Michel Gaulier, Alexandra Boucher, Célian Bertin, Hélène Eysseric-Guérin, Nathalie Fouilhé Sam-Laï","doi":"10.1016/j.therap.2024.10.059","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The DRAMES (décès en relation avec l'abus de médicaments et de substances) registry is a French database of drug-related deaths (medications or illicit drugs) among drug users. The DTA (décès toxiques par antalgiques) registry is a French database of analgesic-related deaths among people without a history of drug abuse. Both registries are based on the collection of data on deaths for which forensic toxicology experts have performed analyses.</p><p><strong>Material and methods: </strong>In the present study, we included drug- and analgesic-related deaths occurring from January 2013 to December 2022 in France. Subject demographic characteristics and medical history, forensic autopsy findings and toxicology reports were evaluated.</p><p><strong>Results: </strong>Among drug users (DRAMES registry), opioids used alone or in combination were the main contributor to drug-related deaths in France, as they are in most countries. However, licit methadone was the leading cause of opioid-related deaths (ahead of heroin) during the study period. The main trend was the dramatic increase in cocaine-related mortality. Among medical users of analgesics (DTA registry), tramadol was the leading cause of deaths throughout this period.</p><p><strong>Conclusion: </strong>A large-scale naloxone distribution program is urgently needed in France to prevent opioid overdoses, including among licit methadone users. However, our data do not support the hypothesis of an opioid crisis in France, although close monitoring is still required, particularly for oxycodone.</p>","PeriodicalId":23147,"journal":{"name":"Therapie","volume":" ","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapie","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.therap.2024.10.059","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: The DRAMES (décès en relation avec l'abus de médicaments et de substances) registry is a French database of drug-related deaths (medications or illicit drugs) among drug users. The DTA (décès toxiques par antalgiques) registry is a French database of analgesic-related deaths among people without a history of drug abuse. Both registries are based on the collection of data on deaths for which forensic toxicology experts have performed analyses.
Material and methods: In the present study, we included drug- and analgesic-related deaths occurring from January 2013 to December 2022 in France. Subject demographic characteristics and medical history, forensic autopsy findings and toxicology reports were evaluated.
Results: Among drug users (DRAMES registry), opioids used alone or in combination were the main contributor to drug-related deaths in France, as they are in most countries. However, licit methadone was the leading cause of opioid-related deaths (ahead of heroin) during the study period. The main trend was the dramatic increase in cocaine-related mortality. Among medical users of analgesics (DTA registry), tramadol was the leading cause of deaths throughout this period.
Conclusion: A large-scale naloxone distribution program is urgently needed in France to prevent opioid overdoses, including among licit methadone users. However, our data do not support the hypothesis of an opioid crisis in France, although close monitoring is still required, particularly for oxycodone.
导言:DRAMES (décès en relation avec l'abus de médicaments et de substances) 登记系统是法国的一个数据库,记录吸毒者中与药物(药物或违禁药物)相关的死亡案例。DTA(décès toxiques par antalgiques)登记处是法国的一个数据库,用于统计无药物滥用史的人群中与镇痛剂相关的死亡案例。这两个登记处都以收集法医毒理学专家已进行分析的死亡数据为基础:在本研究中,我们纳入了 2013 年 1 月至 2022 年 12 月期间在法国发生的与药物和镇痛剂相关的死亡事件。我们对受试者的人口统计学特征、病史、法医尸检结果和毒理学报告进行了评估:在法国的吸毒者(DRAMES登记处)中,与大多数国家一样,单独或混合使用阿片类药物是导致毒品相关死亡的主要原因。然而,在研究期间,合法美沙酮是阿片类药物相关死亡的主要原因(排在海洛因之前)。主要趋势是与可卡因有关的死亡率急剧上升。在镇痛药医疗使用者(DTA 登记册)中,曲马多是这一时期的主要死因:结论:法国急需实施大规模纳洛酮发放计划,以防止阿片类药物过量,包括在美沙酮合法使用者中。不过,我们的数据并不支持法国阿片类药物危机的假设,但仍需密切监测,尤其是对羟考酮的监测。
期刊介绍:
Thérapie is a peer-reviewed journal devoted to Clinical Pharmacology, Therapeutics, Pharmacokinetics, Pharmacovigilance, Addictovigilance, Social Pharmacology, Pharmacoepidemiology, Pharmacoeconomics and Evidence-Based-Medicine. Thérapie publishes in French or in English original articles, general reviews, letters to the editor reporting original findings, correspondence relating to articles or letters published in the Journal, short articles, editorials on up-to-date topics, Pharmacovigilance or Addictovigilance reports that follow the French "guidelines" concerning good practice in pharmacovigilance publications. The journal also publishes thematic issues on topical subject.
The journal is indexed in the main international data bases and notably in: Biosis Previews/Biological Abstracts, Embase/Excerpta Medica, Medline/Index Medicus, Science Citation Index.